NanoGroup S.A.

Warsaw Stock Exchange NNG.WA

NanoGroup S.A. Revenue Per Share for the year ending December 31, 2023: USD 0.00

NanoGroup S.A. Revenue Per Share is USD 0.00 for the year ending December 31, 2023, a -98.66% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • NanoGroup S.A. Revenue Per Share for the year ending December 31, 2022 was USD 0.00, a -73.86% change year over year.
  • NanoGroup S.A. Revenue Per Share for the year ending December 31, 2021 was USD 0.01, a -33.81% change year over year.
  • NanoGroup S.A. Revenue Per Share for the year ending December 31, 2020 was USD 0.01, a 65.68% change year over year.
  • NanoGroup S.A. Revenue Per Share for the year ending December 31, 2019 was USD 0.01, a 192.23% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Warsaw Stock Exchange: NNG.WA

NanoGroup S.A.

CEO Mr. Przemyslaw Daniel Mazurek
IPO Date March 14, 2018
Location Poland
Headquarters Rakowiecka 36
Employees 46
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

NanoGroup S.A. operates as a biotechnology company. It develops and licenses early-stage biotechnology and medical projects in the areas of oncology, transplantology, and blood donations to international biotech companies and pharmaceutical companies. NanoGroup S.A was incorporated in 2016 and is based in Warsaw, Poland.

StockViz Staff

January 15, 2025

Any question? Send us an email